Literature DB >> 111283

Mood alterations during deanol therapy.

D E Casey.   

Abstract

An imbalance between central cholinergic and adrenergic influences may affect mood disorders. Of 38 patients taking high doses of deanol, a putative acetylcholine precursor, eight developed changes in mood: five became depressed and three became hypomanic. A predisposition is suggested as seven of these eight patients had histories of affective symptoms. There was no relationship between the changes in dyskinesias and mood. These observations have both practical and heuristic implications for the management of patients and for further research into the pharmacology of affective disorders and deanol.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111283     DOI: 10.1007/bf00427135

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Quantitative comparisons of the electroencephalographic stimulant effects of deanol, choline, and amphetamine.

Authors:  C C PFEIFFER; L GOLDSTEIN; C MUNOZ; H B MURPHREE; E H JENNEY
Journal:  Clin Pharmacol Ther       Date:  1963 Jul-Aug       Impact factor: 6.875

2.  Increase in rat brain acetylcholine induced by choline or deanol.

Authors:  D R Haubrich; P F Wang; D E Clody; P W Wedeking
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

3.  The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis.

Authors:  D W ROWNTREE; S NEVIN; A WILSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1950-02       Impact factor: 10.154

4.  Parasympathetic suppression of manic symptoms by physostigmine.

Authors:  D S Janowsky; K el-Yousef; J M Davis; H J Sekerke
Journal:  Arch Gen Psychiatry       Date:  1973-04

Review 5.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

Review 6.  Norepinephrine in depressive reactions. A review.

Authors:  W E Bunney; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

7.  Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.

Authors:  J R Stafford; W E Fann
Journal:  Dis Nerv Syst       Date:  1977-12

8.  Physostigmine: effects on cognition and affect in normal subjects.

Authors:  K L Davis; L E Hollister; J Overall; A Johnson; K Train
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

9.  Physostigmine in mania.

Authors:  K L Davis; P A Berger; L E Hollister; E Defraites
Journal:  Arch Gen Psychiatry       Date:  1978-01

10.  Is 2-dimethylaminoethanol (deanol) indeed a precursor of brain acetylcholine? A gas chromatographic evaluation.

Authors:  N R Zahniser; D Chou; I Hanin
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more
  6 in total

Review 1.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

Review 2.  Acetylcholine and affective disorder.

Authors:  S S Leong; W A Brown
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 3.  Pharmacological options for the management of dyskinesias.

Authors:  H Shale; C Tanner
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

Review 4.  Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics.

Authors:  Stephanie C Dulawa; David S Janowsky
Journal:  Mol Psychiatry       Date:  2018-08-17       Impact factor: 15.992

Review 5.  Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.

Authors:  Matěj Malík; Pavel Tlustoš
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

Review 6.  Cholinergic medication for antipsychotic-induced tardive dyskinesia.

Authors:  Irina Tammenmaa-Aho; Rosie Asher; Karla Soares-Weiser; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.